PATIENT, HEALTH PLAN AND COMMUNITY FACTORS ASSOCIATED WITH RECEIPT OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS IN MEDICARE MANAGED CARE PLANS

被引：0
|
作者：
Mehta, S. [1 ]
Teigland, C. [1 ]
Pulungan, Z. [1 ]
Kilgore, K. [1 ]
Parente, A. [1 ]
McClellan, M. [1 ]
Jones, B. [1 ]
机构：
[1] Inovalon, Bowie, MD USA
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
10.1016/j.jval.2015.03.963
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS78
引用
收藏
页码：A166 / A167
页数：4
相关论文
共 50 条
  • [1] Receipt of Disease-Modifying Antirheumatic Drugs Among Patients With Rheumatoid Arthritis in Medicare Managed Care Plans
    Schmajuk, Gabriela
    Trivedi, Amal N.
    Solomon, Daniel H.
    Yelin, Edward
    Trupin, Laura
    Chakravarty, Eliza F.
    Yazdany, Jinoos
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (05): : 480 - 486
  • [2] Factors Associated with the Use of Biologic Disease-modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis
    Hosseini, Roya
    Fawaz, Souhiela
    Seoane-Vazquez, Enrique
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2595 - 2595
  • [3] FACTORS ASSOCIATED WITH BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS UTILIZATION IN RHEUMATOID ARTHRITIS PATIENTS
    Hosseini, R.
    Brown, L.
    Rodriguez-Monguio, R.
    Seoane-Vazquez, E.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S453 - S453
  • [4] FACTORS ASSOCIATED WITH INITIATION OF BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN MOROCCAN PATIENTS WITH RHEUMATOID ARTHRITIS
    Hammou, O.
    Chennouf, F.
    Azzouzi, H.
    Linda, I.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1441 - 1441
  • [5] Use and Spending for Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Among US Medicare Beneficiaries
    Yazdany, Jinoos
    Tonner, Chris
    Schmajuk, Gabriela
    [J]. ARTHRITIS CARE & RESEARCH, 2015, 67 (09) : 1210 - 1218
  • [6] Factors Associated with the Initiation of Biologic Disease-Modifying Antirheumatic Drugs in Texas Medicaid Patients with Rheumatoid Arthritis
    Kim, Gilwan
    Barner, Jamie C.
    Rascati, Karen
    Richards, Kristin
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2015, 21 (05): : 401 - 407
  • [7] Treatment failure with disease-modifying antirheumatic drugs in rheumatoid arthritis patients
    Mittal, Niti
    Mittal, Rakesh
    Sharma, Aman
    Jose, Vinu
    Wanchu, Ajay
    Singh, Surjit
    [J]. SINGAPORE MEDICAL JOURNAL, 2012, 53 (08) : 532 - 536
  • [8] Health Care Effect of Disease-Modifying Antirheumatic Drug Use on Patients with Rheumatoid Arthritis
    Boytsov, Natalie N.
    Bhattacharya, Ritupurna
    Saverno, Kim
    Dixon, Laurin
    Abbott, Paul L.
    Zhang, Xiang
    Gaich, Carol L.
    Nair, Radhika
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (08): : 879 - 887
  • [9] TIME TO AND FACTORS ASSOCIATED WITH INITIATION OF BIOLOGICAL THERAPY WITH DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN COLOMBIA
    Machado-Alba, J. E.
    Calvo-Torres, L. F.
    Banol-Giraldo, A. M.
    Garcia-Betancurt, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 514 - 514
  • [10] Factors associated with discontinuation of glucocorticoids after starting biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients
    Inoue, Mariko
    Kanda, Hiroko
    Tateishi, Shoko
    Fujio, Keishi
    [J]. MODERN RHEUMATOLOGY, 2020, 30 (01) : 58 - 63
12345